| Name | Title | Contact Details |
|---|---|---|
Peter Wang |
Chief Technology Officer | Profile |
Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.
CC Ford Group is a Bernardsville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeuroLogica Corporation is a Danvers, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ALSM is a not-for-profit organization that has been serving families for 60 years. Our services and programs now span eight counties including Bedford, Blair, Cambria, Centre, Clearfield, Fulton, Huntingdon, and Somerset. ALSM currently offers care at
ProCare Health Plan is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.